Comparative molecular similarity indices analysis for predicting anti-HIV activity of phenyl ethyl thiourea (PET) derivatives

Medicinal Chemistry Research

Volumn 17, Issue 1, 2008, Pages 1-11

  Ravichandran, Veerasamy ^a   Kumar, Bommenahath Ravanappa Prashantha ^b   Sankar, Sundaram ^b   Agrawal, Ram Kishore ^a  

^a DR H S GOUR UNIVERSITY   (India)

^b JSS COLLEGE OF PHARMACY   (India)

Author keywords

3D QSAR; Anti HIV; CoMSIA; PET analogues

Indexed keywords

ANTIRETROVIRUS AGENT; PHENYLETHYLTHIOUREA DERIVATIVE; THIOUREA DERIVATIVE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; COMPARATIVE MOLECULAR SIMILARITY INDICES ANALYSIS; CONTROLLED STUDY; DRUG STRUCTURE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROGEN BOND; HYDROPHOBICITY; MOLECULAR MODEL; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

EID: 39049098975     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00044-007-9087-7     Document Type: Article

References (28)

1. S) Bioorg Med Chem 7 2283 2292
2. F Barre-Sinoussi JC Chermann F Rey MT Nugeyre S Chamaret J Gruest C Dauguet C Axler-Blin F Vezinet-Brun C Rouzioux W Rozenbaum L Montagnier 1983 Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS) Science 220 868 871
3. FW Bell AS Cantrell M Hogberg SR Jaskunas NG Johansson CL Jordan MD Kinnic P Lind JM Morin R Noreen B Oberg JA Palkowitz CA Parrish P Pranc C Sahlberg RJ Ternansky RT Vasileff L Vrang SJ West H Zhang XX Zhou 1995 Phenylethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studies of PETT analogs J Med Chem 38 4929 4936
4. M Bohm J Sturzebecher G Klebe 1999 Three-dimensional quantitative structure-activity relationship analyses using comparative molecular field analysis and comparative molecular similarity indices analysis to elucidate selectivity differences of inhibitors binding to trypsin, thrombin, and factor Xa J Med Chem 42 458 477
5. JK Buolamwini H Assefa 2002 CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: Exploration of a binding mode at the active site J Med Chem 45 841 852
6. AS Cantrell P Engelhardt M Hogberg SR Jaskunas NG Johansson CL Jordan MD Kinnic P Lind JM Morin R Noreen B Oberg JA Palkowitz CA Parrish P Pranc C Sahlberg RJ Ternansky RT Vasileff L Vrang SJ West H Zhang 1996 Phenylethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 2. Synthesis and further structure-activity relationship studies of PETT analogs J Med Chem 39 4261 4274
7. HF Chen Q Li XJ Yao BT Fan SG Yuan A Panaye JP Doucet 2003 3D-QSAR and docking study of the binding mode of steroids to progesterone receptor in active site QSAR Comb Sci 22 604 613
8. HF Chen Q Li XJ Yao BT Fan SG Yuan A Panaye JP Doucet 2004 CoMFA/CoMSIA/HQSAR and docking study of the binding mode of selective cyclooxygenase (cox-2) inhibitors QSAR Comb Sci 23 36 55
9. M Clark RD Cramer III: NV Opdenbosch 1989 Validation of the general purpose tripos 5.2 force field J Comput Chem 10 982 1012
10. E De Clercq 1995 Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections J Med Chem 38 2491 2517
11. AK Debnath 1999 Three-dimensional quantitative structure-activity relationship study on cyclic urea derivatives as HIV-1 protease inhibitors: Application of comparative molecular field analysis J Med Chem 42 249 259
12. RC Gallo SZ Salahuddin M Popovic GM Shearer M Kaplan BF Haynes TJ Palker R Redfield J Oleske B Safai 1984 Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS Science 224 500 503
13. A Hilgeroth R Fleischer M Wiese FW Heinemann 1999 Comparison of azacyclic urea A-98881 as HIV-1 protease inhibitor with cage dimeric N-benzyl 4-(4-methozyphenyl)-1, 4-dihydropyridine as representative of a novel class of HIV-1 protease inhibitors: a molecular modeling study J Comput-Aided Mol Des 13 233 242
14. HK Jain RK Agrawal 2006 QSAR analysis of indomethacin derivatives as selective COX-2 inhibitors Internet Electron J Mol Des 5 224 236
15. HK Jain RK Agrawal 2006 Inhibitory mode of 2-acetoxyphenyl alkyl sulfides against COX-1 and COX-2: QSAR analyses Bioorg Med Chem Lett 16 5280 5284
16. PRN Jayatilleke AC Nair R Zauhar WJ Welsh 2000 Computational studies on HIV-1 protease inhibitors: Influence of calculated inhibitor-enzyme binding affinities on the statistical quality of 3D-QSAR CoMFA models J Med Chem 43 4446 4451
17. G Klebe U Abraham T Mietzner 1994 Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity J Med Chem 37 4130 4146
18. JT Leonard K Roy 2006 QSAR by LFER model of HIV protease inhibitor mannitol derivatives using FA-MLR, PCRA and PLS techniques Bioorg Med Chem 14 1039 1046
19. JT Leonard K Roy 2006 Comparative QSAR modeling of CCR5 receptor binding affinity of substituted 1-(3,3-diphenylpropyl)-piperidinyl amides and ureas Bioorg Med Chem Lett 16 4467 4474
20. J Milton MJ Slater AJ Bird D Spinks G Scott CE Price S Downing DVS Green S Madar R Bethell DK Stammers 1998 Biaryl acids: Novel non-nucleoside inhibitors of HIV reverse transcriptase types 1 and 2 Bioorg Med Chem Lett 8 2623 2628
21. AC Nair P Jayatilleke X Wang S Miertus WJ Welsh 2002 Computational studies on tetrahydropyrimidine-2-one HIV-1 protease inhibitors: improving three-dimensional quantitative structure-activity relationship comparative molecular field analysis models by inclusion of calculated inhibitor-and receptor based properties J Med Chem 45 973 983
22. P Pungpo S Hannongbua 2000 Three-dimensional quantitative structure-activity relationships study on HIV-1 reverse transcriptase inhibitors in the class of dipyridodiazepinone derivatives, using comparative molecular field analysis J Mol Graphics Model 18 581 590
23. Ravichandran V, Jain PK, Mourya VK, Agrawal RK (2007a) QSAR study on some arylsulfonamides as anti-hiv agents. Med Chem Res (Inpress)
24. V Ravichandran VK Mourya RK Agrawal 2007 QSAR study of novel 1, 1, 3 - trioxo [1, 2, 4] - thiadiazine (TTDs) analogues as potent anti-HIV agents Arkivoc XIV 204 212
25. V Ravichandran VK Mourya RK Agrawal 2007 QSAR prediction of HIV-1 reverse transcriptase inhibitory activity of benzoxazinone derivatives Internet Electron J Mol Des 6 363 374
26. Sahu KK, Ravichandran V, Jain PK, Mourya VK, Agrawal RK (2007a) QSAR analysis of chicoric acid derivatives as HIV-1 integrase inhibitors. Acta Chim Slov (In press)
27. KK Sahu V Ravichandran VK Mourya RK Agrawal 2007 QSAR analysis of caffeoyl naphthalene sulphonamide derivatives as HIV-1 Integrase inhibitors Med Chem Res 15 418 430
28. SD Young SF Britcher LO Tran LS Payne WC Lumma TA Lyle JR Huff PS Anderson DB Olsen SS Carroll 1995 L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase Antimicrob Agents Chemother 39 2602 2605